Investors / United States / Digitalis Ventures
Digitalis Ventures
Venture capital · New York, NY, United States · North America
Digitalis Ventures provides venture capital to early-stage companies in life sciences, health technologies, and animal health. It is part of the Digitalis Group, alongside Digitalis Commons and Digitalis Labs.
Invests inHealthcare & Biotech
In its own wordsbiomedicinehealth techlife sciencesanimal healthbiotechnology
Your fit with Digitalis Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsDigitalis Ventures lists 14 checked portfolio companies on its own site and is named in 14 funding rounds, 2 of them as lead. Its most frequent entry is Series B, 50% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 86% of its companies are based in United States. It invests most often alongside KdT Ventures, Lightspeed Venture Partners and Samsara BioCapital.
Counts come from funding rounds that name Digitalis Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundDigitalis Ventures does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 14% |
| Series A | 14% |
| Series B | 50% |
| Growth | 21% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 1 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 1 | 0 |
| '25 | 5 | 1 |
| '26 | 7 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 36th | 14 companies |
| Recent activity | 93th | 8 rounds in 12 months |
| Early stage | 56th | 14% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| KdT Ventures | 3 |
| Lightspeed Venture Partners | 3 |
| Samsara BioCapital | 3 |
| Andreessen Horowitz | 2 |
| Bold Capital Partners | 2 |
| Lifeforce Capital | 2 |
| Nextech Invest | 2 |
| Novartis Venture Fund | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers14100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Digitalis Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Digitalis Ventures| Date | Company | Stage |
|---|---|---|
| 5 Nov 2026 | Series B | |
| 7 Oct 2026 | Series B | |
| 23 Sept 2026 | Series C+ | |
| 11 Jun 2026 | Series A | |
| 8 Jun 2026 | Seed | |
| 26 Mar 2026 | Series B Led | |
| 8 Jan 2026 | Series B | |
| 1 Dec 2025 | Series B |
Round details for Digitalis Ventures
Amounts, full round histories and every co-investor in Digitalis Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
14 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Alpha-9 Oncology is a clinical stage radiopharmaceutical company advancing a portfolio of molecules to treat cancer cells | Healthcare & Biotech | Oct 2024Series C+ | Funding round | |
| ASTRA Therapeutics is redefining parasite drug discovery design in Animal Health | Healthcare & Biotech | Jul 2025Seed | Funding round | |
| Clasp connects employers with clinical students before graduation and ties student loan repayments to employment. | Healthcare & Biotech | Mar 2026Series B | Funding round | |
| Elegen produces DNA using cell-free gene synthesis technology | Healthcare & Biotech | Dec 2021Series A | Funding round | |
| Enveda is learning from life to discover medicines | Healthcare & Biotech | Sept 2026Series C+ | Funding round | |
| EpiBiologics develops medicines that use bispecific antibodies to selectively degrade disease-causing extracellular proteins | Healthcare & Biotech | Jan 2026Series B | Funding round | |
| Faeth Therapeutics is developing novel therapeutics to treat cancer | Healthcare & Biotech | Oct 2025Series B | Funding round | |
| Gallant Pet develops regenerative medicine therapies for pets | Healthcare & Biotech | Jun 2025Series B | Funding round | |
| Matchpoint Therapeutics is discovering precision small molecule medicines to transform the treatment of immune diseases. | Healthcare & Biotech | Oct 2026Series B | Funding round | |
| Neion Bio uses genetic engineering to produce medicines from chicken eggs | Healthcare & Biotech | Jun 2026Series A | Funding round | |
| The company provides developmental therapy for autistic children | Healthcare & Biotech | Aug 2025Series C+ | Funding round | |
| Protego Bio is a clinical-stage biotechnology company developing small molecule therapies for protein misfolding diseases, including AL amyloidosis. | Healthcare & Biotech | Dec 2025Series B | Funding round | |
| Rejuvenate Bio develops gene therapy treatments for chronic age-related diseases in animals and humans. | Healthcare & Biotech | Jun 2026Seed | Funding round | |
| T Therapeutics develops drugs for diseases with high unmet medical need, including cancer and autoimmune diseases, using its proprietary platform technologies. | Healthcare & Biotech | Nov 2026Series B | Funding round |
About this data
site last read 5 Nov 2026- Site
- digitalisventures.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 1 Dec 2021
- Companies checked
- 14
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Digitalis Ventures' profile as data
Pull Digitalis Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/digitalisventures.com
# also
GET /v1/firms/digitalisventures.com/portfolio
GET /v1/firms/digitalisventures.com/coinvestors
GET /v1/firms/digitalisventures.com/news